Hemangioblastoma

	WikiDoc Resources for Hemangioblastoma
Articles
Most recent articles on Hemangioblastoma Most cited articles on Hemangioblastoma Review articles on Hemangioblastoma Articles on Hemangioblastoma in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Hemangioblastoma Images of Hemangioblastoma Photos of Hemangioblastoma Podcasts & MP3s on Hemangioblastoma Videos on Hemangioblastoma
Evidence Based Medicine
Cochrane Collaboration on Hemangioblastoma Bandolier on Hemangioblastoma TRIP on Hemangioblastoma
Clinical Trials
Ongoing Trials on Hemangioblastoma at Clinical Trials.gov Trial results on Hemangioblastoma Clinical Trials on Hemangioblastoma at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Hemangioblastoma NICE Guidance on Hemangioblastoma NHS PRODIGY Guidance FDA on Hemangioblastoma CDC on Hemangioblastoma
Books
Books on Hemangioblastoma
News
Hemangioblastoma in the news Be alerted to news on Hemangioblastoma News trends on Hemangioblastoma
Commentary
Blogs on Hemangioblastoma
Definitions
Definitions of Hemangioblastoma
Patient Resources / Community
Patient resources on Hemangioblastoma Discussion groups on Hemangioblastoma Patient Handouts on Hemangioblastoma Directions to Hospitals Treating Hemangioblastoma Risk calculators and risk factors for Hemangioblastoma
Healthcare Provider Resources
Symptoms of Hemangioblastoma Causes & Risk Factors for Hemangioblastoma Diagnostic studies for Hemangioblastoma Treatment of Hemangioblastoma
Continuing Medical Education (CME)
CME Programs on Hemangioblastoma
International
Hemangioblastoma en Espanol Hemangioblastoma en Francais
Business
Hemangioblastoma in the Marketplace Patents on Hemangioblastoma
Experimental / Informatics
List of terms related to Hemangioblastoma

	Hemangioblastoma;
ICD-O:	9161/1
DiseasesDB	31512
MeSH	C04.557.645.375.380.370

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Hemangioblastoma of the central nervous system is a benign tumor (WHO grade I) that is typically cystic and can occur throughout the central nervous system. It is a tumor composed of hemangioblasts, a type of stem cell that normally give rise to blood vessels or blood cells. Its name breaks down to Greek roots as follows: Haema (blood), angeion (vessel), blastos (embryonic), oma (tumor).

Locations

Predominant locations include the cerebellum and spinal cord.

Causes

Hemangioblastomas can occur "sporadically", or as a component of the von Hippel-Lindau disease (VHL).

VHL is inherited in an autosomal dominant pattern. The VHL gene behaves as a tumor suppressor, i.e. mutation of the VHL gene predisposes individuals to development of a wide variety of benign and malignant tumors. These tumors occur in target tissues such as the kidneys, adrenal gland, central nervous system and retina.

The most common tumors in VHL besides hemangioblastomas are pheochromocytomas, retinal angiomas, clear cell renal cancer and renal cysts, pancreatic cysts and pancreatic islet cell tumors, and cystadenomas of the epididymis. All of these tumors can also occur sporadically outside VHL, presumably with a similar underlying pathophysiology.)

Presentation

These tumors, whether benign (usual) or malignant (rarer), may cause clinically significant problems, for example angiomas in the brain or spinal cord may press on nerve or brain tissue.

As an angioma grows, the walls of the blood vessels may weaken and leak, causing damage to surrounding tissues. Blood leakage from angiomas in the retina can interfere with vision.

Cysts may also grow around angiomas.

Cerebral hemangioblastomas are commonly seen at MR imaging as cystic lesion with a solid enhancing mural nodule. The solid nodule give low signal on diffusion weighted imaging (DWI) with resultant increase in the apparent diffusion coefficient (ADC).